Organization model for allotransplantations of cryopreserved
vascular grafts in Czech Republic

J 2018

Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC et. al.

Základní údaje

Originální název

Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic

Autoři

ŠPAČEK, Miroslav (203 Česká republika, garant), Pavel SMĚŘIČKA (203 Česká republika), Libor JANOUŠEK (203 Česká republika), Petr ŠTÁDLER (203 Česká republika), Miloš ADAMEC (203 Česká republika), Robert VLACHOVSKÝ (203 Česká republika, domácí), Igor GUŇKA (203 Česká republika), Pavel NAVRÁTIL (203 Česká republika), Filip THIEME (203 Česká republika), Petr MITÁŠ (203 Česká republika), Rudolf ŠPUNDA (203 Česká republika), Jaroslav ŠPATENKA (203 Česká republika), Robert STAFFA (203 Česká republika, domácí), Petr NĚMEC (203 Česká republika) a Jaroslav LINDNER (203 Česká republika)

Vydání

Cell and Tissue Banking, Dordrecht, Springer, 2018, 1389-9333

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10601 Cell biology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.939

Kód RIV

RIV/00216224:14110/18:00104200

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s10561-018-9691-4

UT WoS

000442599400018

Klíčová slova anglicky

Vascular allograft; Cryopreservation; Tissue transplantation; Organization model

Štítky

14110121, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 2. 2019 17:08, Soňa Böhmová

Anotace

V originále

The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.

Citovat

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC, Robert VLACHOVSKÝ, Igor GUŇKA, Pavel NAVRÁTIL, Filip THIEME, Petr MITÁŠ, Rudolf ŠPUNDA, Jaroslav ŠPATENKA, Robert STAFFA, Petr NĚMEC a Jaroslav LINDNER. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell and Tissue Banking. Dordrecht: Springer, 2018, roč. 19, č. 3, s. 437-445. ISSN 1389-9333. Dostupné z: https://dx.doi.org/10.1007/s10561-018-9691-4.

@article{1455336,
   author = {Špaček, Miroslav and Směřička, Pavel and Janoušek, Libor and Štádler, Petr and Adamec, Miloš and Vlachovský, Robert and Guňka, Igor and Navrátil, Pavel and Thieme, Filip and Mitáš, Petr and Špunda, Rudolf and Špatenka, Jaroslav and Staffa, Robert and Němec, Petr and Lindner, Jaroslav},
   article_location = {Dordrecht},
   article_number = {3},
   doi = {http://dx.doi.org/10.1007/s10561-018-9691-4},
   keywords = {Vascular allograft; Cryopreservation; Tissue transplantation; Organization model},
   language = {eng},
   issn = {1389-9333},
   journal = {Cell and Tissue Banking},
   title = {Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic},
   volume = {19},
   year = {2018}
}

TY  - JOUR
ID  - 1455336
AU  - Špaček, Miroslav - Směřička, Pavel - Janoušek, Libor - Štádler, Petr - Adamec, Miloš - Vlachovský, Robert - Guňka, Igor - Navrátil, Pavel - Thieme, Filip - Mitáš, Petr - Špunda, Rudolf - Špatenka, Jaroslav - Staffa, Robert - Němec, Petr - Lindner, Jaroslav
PY  - 2018
TI  - Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic
JF  - Cell and Tissue Banking
VL  - 19
IS  - 3
SP  - 437-445
EP  - 437-445
PB  - Springer
SN  - 13899333
KW  - Vascular allograft
KW  - Cryopreservation
KW  - Tissue transplantation
KW  - Organization model
N2  - The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.
ER  -

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC, Robert VLACHOVSKÝ, Igor GUŇKA, Pavel NAVRÁTIL, Filip THIEME, Petr MITÁŠ, Rudolf ŠPUNDA, Jaroslav ŠPATENKA, Robert STAFFA, Petr NĚMEC a Jaroslav LINDNER. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. \textit{Cell and Tissue Banking}. Dordrecht: Springer, 2018, roč.~19, č.~3, s.~437-445. ISSN~1389-9333. Dostupné z: https://dx.doi.org/10.1007/s10561-018-9691-4.

Podrobný výpis o publikaci